Blood advances

AbstractIron-deficiency anemia (IDA) affects nearly one-third of women globally, with heavy menstrual bleeding (HMB) being a significant risk factor among those of reproductive age. Despite the substantial burden of HMB-related IDA, patient…

Preservation of fertility has become a growing concern in young females with Hodgkin lymphoma (HL). However, the rate of pregnancy after the current most frequently prescribed ABVD (doxorubicin [Adriamycin], bleomycin, vinblastine, and darc…

Backgroundvon Willebrand disease (VWD) is a common inherited bleeding disorder. Significant variability exists in management options offered to patients.ObjectiveThese evidence-based guidelines from the American Society of Hematology (ASH),…

BackgroundDespite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients.ObjectiveThese evide…